Latest Revenue Milestones News

Life360 reported record Q2 2025 results with robust subscription growth and raised full-year guidance, alongside a strategic leadership transition appointing Lauren Antonoff as CEO.

IODM Limited has triggered a significant increase in its guaranteed minimum monthly revenue from its UK Education segment, reflecting a remarkable 242% growth in July 2025 compared to last year. This milestone boosts the annualised minimum payment to AUD 2.39 million, underscoring the strength of its digital accounts receivable platform.

Light & Wonder reported a slight revenue dip in Q2 2025 but expanded earnings and margins, fueled by its $850 million Grover acquisition and a strategic shift to a sole ASX listing.

Raptis Group Limited has secured $16.6 million in revenue through two related party transactions, pending shareholder approval. These deals, facilitated by its subsidiary FSU Capital, highlight ongoing strategic partnerships within the company’s leadership circle.

Thrive Tribe Technologies reports early commercial traction with its new digital services model, alongside a completed 20 – 1 capital consolidation and ongoing funding initiatives.

Resonance Health reports a solid quarter with key clinical trial milestones, expansion of trial sites, and multi-year Software-as-a-Medical Device contracts, underpinning a positive cashflow outlook.

Pointerra Limited reported strong FY25 Q4 results marked by new enterprise customers, a major US defense subcontract, and significant cashflow improvements. The company’s AI-enhanced digital twin platform is gaining traction across multiple sectors, setting the stage for growth in FY26.

Rent.com.au has reported its strongest half-year revenue to date, driven by robust growth in its RentBond and RentPay platforms, alongside launching self-funded RentBond loans backed by a $10 million debt facility.

Kinatico Limited has reported a record FY25 revenue of $32.1 million, driven by a remarkable 54% increase in SaaS revenue and a cash-positive year despite significant technology investments.

Nova Eye Medical has reported a record A$28.8 million in revenues for FY25, driven by strong US sales and sustained growth of its flagship iTrack™ Advance device.

BCAL Diagnostics has secured a strategic partnership with Cancer Care Associates to fast-track the clinical adoption and revenue generation of its innovative BREASTEST plus™ breast cancer blood test starting FY2026.

Orthocell Limited has posted a record quarterly revenue of A$2.73 million, driven by strong Australian sales of its nerve repair product Remplir™, with US market expansion poised to accelerate in FY26.